Cresset raises £7.3m in Series C funding from Scottish Equity Partners to expand its software platform and international operations.
Scottish Equity Partners led the Series C financing to support international expansion and product development.
£7.3MSeries C
Cresset develops computational software and design solutions for drug discovery teams. Its tools support research chemists globally across the pharmaceutical and life sciences sectors.
Cresset has secured £7.3m in a Series C funding round led by Scottish Equity Partners. The company provides computational software and discovery services designed to streamline the drug discovery pipeline for research organisations.
The capital will be deployed to accelerate product development, recruit specialist talent, and expand operations internationally, with a particular focus on the United States market.
Use of funds
- 01Continue product development
- 02Grow the team
- 03Expand into international markets
- 04Scale operations
